GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Amedisys Inc (STU:ADY) » Definitions » Cyclically Adjusted FCF per Share

Amedisys (STU:ADY) Cyclically Adjusted FCF per Share : €4.08 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Amedisys Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Amedisys's adjusted free cash flow per share for the three months ended in Mar. 2024 was €-0.263. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €4.08 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Amedisys's average Cyclically Adjusted FCF Growth Rate was 5.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 8.40% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 4.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Amedisys was 112.10% per year. The lowest was -3.90% per year. And the median was 4.70% per year.

As of today (2024-05-15), Amedisys's current stock price is €87.00. Amedisys's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €4.08. Amedisys's Cyclically Adjusted Price-to-FCF of today is 21.32.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Amedisys was 95.88. The lowest was 3.55. And the median was 21.08.


Amedisys Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Amedisys's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amedisys Cyclically Adjusted FCF per Share Chart

Amedisys Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.59 2.56 3.21 3.86 3.96

Amedisys Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.87 3.96 3.99 3.96 4.08

Competitive Comparison of Amedisys's Cyclically Adjusted FCF per Share

For the Medical Care Facilities subindustry, Amedisys's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amedisys's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Amedisys's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Amedisys's Cyclically Adjusted Price-to-FCF falls into.



Amedisys Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Amedisys's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.263/129.4194*129.4194
=-0.263

Current CPI (Mar. 2024) = 129.4194.

Amedisys Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -2.092 100.560 -2.692
201409 0.578 100.428 0.745
201412 0.060 99.070 0.078
201503 0.349 99.621 0.453
201506 0.746 100.684 0.959
201509 0.779 100.392 1.004
201512 0.459 99.792 0.595
201603 0.149 100.470 0.192
201606 0.302 101.688 0.384
201609 0.085 101.861 0.108
201612 0.737 101.863 0.936
201703 0.623 102.862 0.784
201706 0.860 103.349 1.077
201709 0.209 104.136 0.260
201712 0.749 104.011 0.932
201803 0.911 105.290 1.120
201806 1.265 106.317 1.540
201809 1.688 106.507 2.051
201812 1.688 105.998 2.061
201903 0.507 107.251 0.612
201906 1.552 108.070 1.859
201909 1.205 108.329 1.440
201912 2.001 108.420 2.389
202003 0.125 108.902 0.149
202006 3.566 108.767 4.243
202009 2.088 109.815 2.461
202012 1.571 109.897 1.850
202103 1.326 111.754 1.536
202106 1.677 114.631 1.893
202109 1.534 115.734 1.715
202112 0.102 117.630 0.112
202203 1.316 121.301 1.404
202206 1.598 125.017 1.654
202209 -0.479 125.227 -0.495
202212 1.126 125.222 1.164
202303 0.698 127.348 0.709
202306 1.499 128.729 1.507
202309 -0.315 129.860 -0.314
202312 1.636 129.419 1.636
202403 -0.263 129.419 -0.263

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Amedisys  (STU:ADY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Amedisys's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=87.00/4.08
=21.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Amedisys was 95.88. The lowest was 3.55. And the median was 21.08.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Amedisys Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Amedisys's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Amedisys (STU:ADY) Business Description

Traded in Other Exchanges
Address
3854 American Way, Suite A, Baton Rouge, LA, USA, 70816
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Amedisys (STU:ADY) Headlines

No Headlines